Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis

By Chrysant Steven G.   Murray Alexander V.   Hoppe Uta C.   Dattani Dan   Patel Samir   Hsu Huang   Zhang Jack  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1039-1047

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension

By Chrysant Steven G.   Murray Alexander V.   Hoppe Uta C.   Dattani Dan   Patel Samir   Ritter Shannon   Zhang Jack  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2841-2849

Informa Healthcare

Access to resources Recommend Favorite

Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study*

By Philipp Thomas   Glazer Robert D.   Zhao Yanxing   Pospiech Rainer  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy

By Schunkert H   Glazer R.D.   Wernsing M.   Yen J.   Macarie C.E.   Vintila M.M.   Romanova J  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2655-2662

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy

By Farnier Michel   Ducobu Jean   Bryniarski Leszek  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2165-2173

Informa Healthcare

Access to resources Recommend Favorite